RECOVERY / SINGLE
TB-500 (THYMOSIN B4 ACETATE)
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
The active region of thymosin beta-4, studied in tissue-repair and regeneration research.
Available Strengths
- 5MG (BT5)
- 10MG (BT10)
Research Protocol
Reference gradual schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.5 mg | 30 | 0.3 mL |
| Weeks 3–4 | 0.6 mg | 36 | 0.36 mL |
| Weeks 5–8 | 0.75 mg | 45 | 0.45 mL |
| Weeks 9–12 | 1 mg | 60 | 0.6 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Preclinical evidence discussed in the cited research suggests it promotes angiogenesis, supports wound-healing acceleration and enhances cell migration through actin-binding activity.
Storage
−20°C, dry conditions. 2–8°C, do not freeze; use within 28 days with bacteriostatic water preservative.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source